Ranbaxy Laboratories is planning to sell India-made generic medicines in Japan, according to media reports.
Report said that the company also plans to boost its consolidated revenues.
Ranbaxy reported: "The product selection procedure for launch in Japan has been finalised. The hybrid business model between Ranbaxy and Daiichi Sankyo continues on several fronts."
Ranbaxy and Daiichi Sankyo are in advanced talks with Japan's Ministry of Health, Labour and Welfare, which regulates medicines, report said.
Report said that the company also plans to boost its consolidated revenues.
Ranbaxy reported: "The product selection procedure for launch in Japan has been finalised. The hybrid business model between Ranbaxy and Daiichi Sankyo continues on several fronts."
Ranbaxy and Daiichi Sankyo are in advanced talks with Japan's Ministry of Health, Labour and Welfare, which regulates medicines, report said.
No comments:
Post a Comment